Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionGolden State Equity Partners
Latest Disclosed Ownership325 shares
Latest Disclosed Value $ 11,943
Golden State Equity Partners ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 28, 2026 - Golden State Equity Partners filed a 13F-HR form disclosing ownership of 325 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $10,254 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 0 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). The current value of the position is $11,642 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F NOVO-NORDISK A S FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 670100205 325 325 12 0.0009
2026-01-29 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 0 -14,337 -100.00 0 -100.00
2025-10-21 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 14,337 -775 -5.13 796 -23.78 0.1341
2025-07-14 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 15,112 11,983 382.97 1,043 380.65 0.1931
2025-04-23 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 3,129 -17 -0.54 217 -19.63 0.0430
2025-01-24 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 3,146 2,410 327.45 271 210.34 0.0517
2024-10-29 2024-09-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 736 -2,841 -79.42 88 -82.94 0.0461
2024-10-25 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 2,289 -1,288 273 0.0605
2024-07-29 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 3,577 33 0.93 511 39.34 0.1063
2024-02-02 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 3,544 23 0.65 367 14.38 0.0890
2023-10-20 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 3,521 1,698 93.14 320 8.47 0.0892
2023-07-19 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 1,823 -246 -11.89 295 -10.33 0.0829
2023-06-01 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 2,069 2,069 329 0.1782
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.